March 3, 2017 Conference


Management of Diabetic Eye Disease: Optimizing Outcomes in the Era of Anti-VEGF

Return to Session

Judy Kim (Presenter)
Speaker Session Topic
Discovery of vascular endothelial growth factor (VEGF) and the use of anti-VEGF agents have revolutionized our management of diabetic retinopathy. Various clinical trials have shown benefit of these agents in the management of diabetic macular edema and proliferative diabetic retinopathy. However, clinical trial treatment protocols may not be easily translated and incorporated into practical day to day management of our patients in the clinic. We will review findings from key DRCRnet findings and discuss ways to optimize patient outcomes in an evidence based manner.